M&A / Deals Gilead inks $140M API supply deal, tightening ties to Korean manufacturer BioSpaceThe agreement is the largest in a series of deals that Gilead Sciences has penned with Korea's Yuhan.Read full story pharminent May 22, 2026 (Last updated: May 22, 2026) BioSpace The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: GBL joins CVC in 10.7bn takeover bid for RecordatiNext: Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
